Table 3.
Summary Outcomes: Antibiotic Prescriptions by Malaria and Respiratory Disease Status
| Malaria RDT and Disease Status | Patients With ATBs Prescribed/Total in Group, No. (%) | Effect | |||
|---|---|---|---|---|---|
| Intervention Group | Control Group | Relative: RR (95% CI) |
Absolute: RD (95% CI) |
No. Needed to Testa | |
| Malaria RDT negative | 504/1187 (42.5) |
669/1107 (60.4) |
30% Reduction (−24% to −35%) |
18 Fewer ATB Rx per 100 patients tested (14–22 fewer) |
1 Fewer ATB Rx for every 6 patients tested (range: 7 to 5 patients) |
| Respiratory disease | 747/1511 (49.4) |
743/1177 (63.1) |
23% Reduction (−18% to −28%) |
15 Fewer ATB Rx per 100 patients tested (11–18 fewer) |
1 Fewer ATB Rx every 7 patients tested (range: 9 to 6 patients) |
| Malaria RDT negative and respiratory disease | 390/938 (41.6) |
443/751 (59) |
31% Reduction (−24% to −33%) |
18 Fewer ATB Rx per 100 patients tested (13–22 fewer) |
1 Fewer ATB Rx for every 6 patients tested (range: 8 to 5 patients) |
Abbreviations: ATB, antibiotic; CI, confidence interval; RD, risk difference; RDT, rapid diagnostic test; RR, risk ratio; Rx, prescription(s).
Number needed to test to prevent 1 more ATB Rx if results were negative.